PCN40 Healthcare Resource Utilization in Patients Treated with Encorafenib PLUS Binimetinib for BRAF-Mutant Metastatic Melanoma: DATA from Columbus, a Phase 3 Trial in BRAF-Mutant Melanoma
Abstract
Authors
M. Mandala A. Arance R. Dummer P.A. Ascierto H. Gogas G. Liszkay C. Garbe D. Schadendorf I. Krajsová R. Gutzmer V. Chiarion Sileni C. Dutriaux C. Loquai A. Tadmouri M.D. Pickard A. Gollerkeri C. Robert K.T. Flaherty